• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病质量激励计划:当前在制定衡量标准、推动改进和激励成果方面证据与数据的局限性

The ESRD Quality Incentive Program: The Current Limitations of Evidence and Data to Develop Measures, Drive Improvement, and Incentivize Outcomes.

作者信息

Diamond Louis H, Howard Andrew D

机构信息

Quality Health Care Advisory Group, Huntington, NY; and Metropolitan Nephrology Associates, Clinton, MD.

Quality Health Care Advisory Group, Huntington, NY; and Metropolitan Nephrology Associates, Clinton, MD.

出版信息

Adv Chronic Kidney Dis. 2016 Nov;23(6):377-384. doi: 10.1053/j.ackd.2016.11.007.

DOI:10.1053/j.ackd.2016.11.007
PMID:28115082
Abstract

This article describes the current state of facilitating the integration of evidence into practice to support initiatives focused on patients with ESRD. We will use the Centers for Medicare and Medicaid Services (CMS) ESRD Quality Incentive Program (QIP) as an example, including a description of the health information infrastructure needed to support the translation of evidence into practice and some of the challenges encountered. The process from the generation of evidence to integration of this evidence into practice includes policy development leading to clinical practice guidelines, clinical performance measures, and clinical decision support tools. The ESRD QIP is the most mature program outside the hospital initiatives in the CMS Quality Payment Program and currently contains 16 measures. ESRD data to support these measures are aggregated at the dialysis facility level and reported through the CMS Consolidated Renal Operations in a Web-enabled Network (CROWNWeb) and the Centers for Disease Control and Prevention using the National Healthcare Safety Network. We review these measures and the health information infrastructure used to report the data, focusing on the inherent strengths and weaknesses of the ESRD QIP along with opportunities for improvement of the program.

摘要

本文描述了促进将证据整合到实践中以支持针对终末期肾病(ESRD)患者的倡议的当前状况。我们将以医疗保险和医疗补助服务中心(CMS)的ESRD质量激励计划(QIP)为例,包括对支持将证据转化为实践所需的健康信息基础设施的描述以及所遇到的一些挑战。从证据产生到将该证据整合到实践中的过程包括导致临床实践指南、临床绩效指标和临床决策支持工具的政策制定。ESRD QIP是CMS质量支付计划中医院外倡议中最成熟的计划,目前包含16项指标。支持这些指标的ESRD数据在透析机构层面进行汇总,并通过CMS基于网络的综合肾脏运营(CROWNWeb)以及疾病控制与预防中心使用国家医疗安全网络进行报告。我们审查这些指标以及用于报告数据的健康信息基础设施,重点关注ESRD QIP固有的优势和劣势以及该计划的改进机会。

相似文献

1
The ESRD Quality Incentive Program: The Current Limitations of Evidence and Data to Develop Measures, Drive Improvement, and Incentivize Outcomes.终末期肾病质量激励计划:当前在制定衡量标准、推动改进和激励成果方面证据与数据的局限性
Adv Chronic Kidney Dis. 2016 Nov;23(6):377-384. doi: 10.1053/j.ackd.2016.11.007.
2
Do current quality measures truly reflect the quality of dialysis?当前的质量指标真的能反映透析质量吗?
Semin Dial. 2018 Jul;31(4):406-414. doi: 10.1111/sdi.12685. Epub 2018 Feb 26.
3
Changes to the end-stage renal disease quality incentive program.终末期肾病质量激励计划的变化。
Kidney Int. 2012 Jun;81(12):1167-71. doi: 10.1038/ki.2012.138. Epub 2012 Apr 25.
4
Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States.美国独立透析中心质量激励计划评分与新透析患者死亡率的关系
Am J Kidney Dis. 2020 Feb;75(2):177-186. doi: 10.1053/j.ajkd.2019.07.023. Epub 2019 Nov 1.
5
The ESRD Quality Incentive Program-Can We Bridge the Chasm?终末期肾病质量激励计划——我们能弥合差距吗?
J Am Soc Nephrol. 2017 Jun;28(6):1697-1706. doi: 10.1681/ASN.2016101079. Epub 2017 Mar 15.
6
The Role of Social Risk Factors in Dialysis Quality and Patient Outcomes Under a Medicare Quality Incentive Program.社会风险因素在医疗保险质量激励计划下对透析质量和患者预后的作用。
Med Care. 2022 Oct 1;60(10):735-742. doi: 10.1097/MLR.0000000000001750. Epub 2022 Jul 26.
7
The QIP: will it improve dialysis care? An overview.质量改进计划(QIP):它会改善透析护理吗?概述。
Nephrol News Issues. 2012 Jan;26(1):20, 22-4, 26.
8
Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.医疗保险计划;终末期肾病前瞻性支付系统、为急性肾损伤患者提供的肾透析服务的覆盖范围和支付、终末期肾病质量激励计划、耐用医疗设备、假肢、矫形器及用品竞争性投标计划投标保证金、违反合同行为的州许可和上诉程序、耐用医疗设备、假肢、矫形器及用品竞争性投标计划和费用表调整、耐用医疗设备的就医问题;以及终末期肾病综合护理模式。最终规则。
Fed Regist. 2016 Nov 4;81(214):77834-969.
9
How the ESRD quality incentive program could potentially improve quality of life for patients on dialysis.终末期肾病质量激励计划如何有可能改善透析患者的生活质量。
Clin J Am Soc Nephrol. 2015 May 7;10(5):888-93. doi: 10.2215/CJN.07410714. Epub 2015 Mar 4.
10
Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.独立透析中心规模与医疗保险质量激励计划绩效评分之间的关联。
Am J Nephrol. 2019;49(1):64-73. doi: 10.1159/000495262. Epub 2018 Dec 17.

引用本文的文献

1
Pay-for-performance programs effectiveness in healthcare: the case of the end-stage renal disease quality incentive program.医疗保健中按绩效付费计划的有效性:以终末期肾病质量激励计划为例。
Eur J Health Econ. 2024 Mar;25(2):221-236. doi: 10.1007/s10198-023-01582-x. Epub 2023 Mar 26.
2
Patient-Reported Outcome Dashboards Within the Electronic Health Record to Support Shared Decision-making: Protocol for Co-design and Clinical Evaluation With Patients With Advanced Cancer and Chronic Kidney Disease.电子健康记录中的患者报告结局仪表盘以支持共同决策:与晚期癌症和慢性肾脏病患者共同设计和临床评估的方案
JMIR Res Protoc. 2022 Sep 21;11(9):e38461. doi: 10.2196/38461.
3
Validation of Algorithms Used to Identify Red Blood Cell Transfusion Related Admissions in Veteran Patients with End Stage Renal Disease.
用于识别终末期肾病退伍军人患者红细胞输血相关住院情况的算法验证
EGEMS (Wash DC). 2019 Jul 3;7(1):23. doi: 10.5334/egems.257.